Part of the High-Risk Plaque (HRP) Initiative the BioImage study uses CMR to assess both atherosclerosis in the aorta and carotids. I also integrates CT, IMT, US and ABI markers and has already enrolled over 6800 patients.
The study is accepting new proposals from institutions to participate in the initiative. Further details can be found at:
Most of the readers believe CMR should be performed in every patient with HCM. Based on the latest data published recently it is hard to argue against that.
New prognostic information regarding CMR and severe aortic valve disease was published by a Brazilian group conducted by Dr. Clerio Azevedo. Should we only indicate aortic sugergy in patients with small amounts of fibrosis? A tough question that is raised by the paper and should generate more use of CMR in these conditions.
A paper in JACC commenting on how to measure myocardial fibrosis, a very important issue involving many cardiac diseases. CMR is represented by LGE, T1 mapping and tissue tagging.